A brief overview of acute respiratory distress syndrome

World Journal of Surgery

Volumn 30, Issue 10, 2006, Pages 1829-1834

  Hardaway, Robert M ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; UROKINASE;

ABSENCE OF SIDE EFFECTS; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; HUMAN; LUNG ALVEOLUS OXYGEN TENSION; LUNG INSUFFICIENCY; MUSCLE INJURY; NONHUMAN; SEPTIC SHOCK;

ANIMALS; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; DOGS; HUMANS; PLASMINOGEN ACTIVATORS; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SHOCK, TRAUMATIC; SWINE; TREATMENT OUTCOME;

EID: 33749005358     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-006-0030-8     Document Type: Article

References (42)

1. The Medical Department of the United States Army in the World War. Surgery 1927;2:185.
2. Hardaway RM. Disseminated intravascular coagulation syndrome. Arch Surg 1961;83:842-850.
3. Hardaway RM. Syndromes of Disseminated Intravascular Coagulation with Special Reference to Shock and Hemorrhage. Springfield, IL, Charles C Thomas Publisher, 1966.
4. Hardaway RM. Pulmonary microthrombi (presented at symposium on pulmonary embolic disease, Boston, MA, 22 May 1964). In Sasahara AA, ed, Pulmonary Embolic Disease, New York, Bruce-Shatton, 1965:65-72.
5. Hardaway RM, James PM, Anderson RW, et al. Intensive study and treatment of shock in man. JAMA 1967;199:779-790.
6. Hardaway RM. Shock lung. Int Surg 1973;58:311-315.
7. Hardaway RM. Care of the Wounded in Viet Nam, Manhattan, KS, Sunflower University Press, 1988:139-221.
8. Collins JA, Gordon WC Jr, Hudson TL, et al. Inapparent hypoxemia in casualties with wounded limbs. Ann Surg 1968;167:511-520.
9. Bredenberg CE, James PM, Collins J, et al. Respiratory failure in shock. Ann Surg 1969;169:220.
10. Collins JA. The cause of progressive pulmonary insufficiency in surgical patients. J Surg Res 1969:9.
11. Martin AM, Simmons RL, Heisterkamp CA 3rd, et al. Respiratory insufficiency in combat casualties. I. Pathologic changes in the lungs of patients dying of wounds. Ann Surg 1969;170:30-38.
12. Simmons RL, Martin AM, Heisterkamp CA 3rd, et al. Respiratory insufficiency in combat casualties. II. Pulmonary edema following head injury. Ann Surg 1969;170:39-44.
13. Simmons RL, Heisterkamp CA 3rd, Martin AM, et al. Respiratory insufficiency in combat casualties. III. Arterial hypoxemia after wounding. Ann Surg 1969;170:45-52.
14. Simmons RL, Heisterkamp CA 3rd, Collins JA, et al. Acute pulmonary edema in battle casualties. J Trauma 1969;9:760-775.
15. Chiu D, Lubin B, Shohet SB. Erythrocyte membrane lipid reorganization during the sickling process. Br J Hematol 1974;41:223-234.
16. Feola M, Simoni J, Cnizaro PC, et al. Toxicity of polymerized hemoglobin solutions. Surg Gynecol Obstet 1988;166:211-222.
17. Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 196;7:319-323.
18. Ashbaugh DG, Petty TL, Bigelow DB, et al. Continuous positive pressure breathing in ARDS. J Thorac Cardiovasc Surg 1969:57.
19. Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997;336:952-953.
20. Zeni F, Freeman BF, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock, a reassessment. Crit Care Med 1997;25:1095-1100.
21. Natanson C, Hoffman WD, Suffredini AF. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771-783.
22. Fein AM, Calalang-Colucci MG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 2000;16:289-317.
23. Baue AE. MOF, MODS, SIRS: Why no magic bullets? Arch Surg 1997;132:703-707.
24. U.S. Department of Commerce Bureau of Census Statistical Abstract of the United States 1995.
25. Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000;16:337-352.
26. Bernard GR, Vincent VL, Laterre PF. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
27. Hardaway RM, Williams CH, Vasquez Y. Disseminated intravascular coagulation in sepsis. Semin Thrombosis Hemost 2001;27:577-583.
28. Hardaway RM, Vasquez Y. A shock toxin that produces disseminated intravascular coagulation and multiple organ failure. Am J Med Sci 2001;322:222-228.
29. Hardaway RM. A review of septic shock. Am Surg 2000;66:22-29.
30. Gando S, Nanzaki S, Morimoto Y, et al. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma 1999;47:719-723.
31. Gando S, Kamene T, Nanzaki S, et al. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 1997;25:1820-1826.
32. Gando S, Kamene T, Morimoto Y, et al. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med 2001;8:1729-1734.
33. Gando S, Kamene T, Matsuda N, et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thrombohemostasis 2002;88:943-949.
34. Gando S, Nanzaki S, Kemmotsu. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunction after trauma. Ann Surg 1999;229:121-127.
35. Gando S, Kamene T, Nanzaki S, et al. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thrombohemostasis 1996;75:224-228.
36. Gando S, Nanzaki S, Aoi K, et al. Activation of the extrinsic coagulation pathway in patients with sepsis and septic shock. Crit Care Med 1998;26:2005-2009.
37. Oberhofer D, Kueisee-Tepes N, et al. Coagulation tests in septic shock patients. Acta Med Croatia 2004;58:389-394.
38. Hardaway RM, Williams CH, Marvasti M, et al. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Crit Care Med 1990;18:1413-1418.
39. Hardaway RM, Burns VW. Mechanism of action of fibrinolysin in the prevention of "irreversible" hemorrhagic shock. Ann Surg 1963;157:305-309.
40. Hardaway RM. Traumatic and septic shock alias posttrauma critical illness. Br J Surg 1998;85:1473-1479.
41. Hardaway RM, Harke H, Tyroch A. Treatment of acute respiratory distress syndrome: a final report on a Phase I study. Am Surg 2001;67:377-382.
42. Hardaway RM. Traumatic shock. Mil Med 200;6:171.